IL10 and obesity disorder: A very recent study demonstrated that glucagon-like peptide-1 (GLP-1), a gut hormone that is used to treat obesity and diabetes, activates adipose iNKT cells and enhances the secretion of anti-inflammatory cytokines including IL-10 in WAT (60).